In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors.
In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. 2021 09; 39(15):5756-5767.